264 related articles for article (PubMed ID: 29233215)
1. Unraveling amyloid formation paths of Parkinson's disease protein α-synuclein triggered by anionic vesicles.
Kiskis J; Horvath I; Wittung-Stafshede P; Rocha S
Q Rev Biophys; 2017 Jan; 50():e3. PubMed ID: 29233215
[TBL] [Abstract][Full Text] [Related]
2. [The processes of α-synuclein amyloid protein complexes involved in the pathogenesis of Parkinson's disease].
Kiskis J; Horvath I; Wittung-Stafshede P; Rocha S
Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(8):75-81. PubMed ID: 30251982
[TBL] [Abstract][Full Text] [Related]
3. A Downsized and Optimised Intracellular Library-Derived Peptide Prevents Alpha-Synuclein Primary Nucleation and Toxicity Without Impacting Upon Lipid Binding.
Meade RM; Watt KJC; Williams RJ; Mason JM
J Mol Biol; 2021 Dec; 433(24):167323. PubMed ID: 34695381
[TBL] [Abstract][Full Text] [Related]
4. C-Terminal Truncated α-Synuclein Fibrils Contain Strongly Twisted β-Sheets.
Iyer A; Roeters SJ; Kogan V; Woutersen S; Claessens MMAE; Subramaniam V
J Am Chem Soc; 2017 Nov; 139(43):15392-15400. PubMed ID: 28968082
[TBL] [Abstract][Full Text] [Related]
5. N-alpha-acetylation of α-synuclein increases its helical folding propensity, GM1 binding specificity and resistance to aggregation.
Bartels T; Kim NC; Luth ES; Selkoe DJ
PLoS One; 2014; 9(7):e103727. PubMed ID: 25075858
[TBL] [Abstract][Full Text] [Related]
6. Anionic lipid vesicles have differential effects on the aggregation of early onset-associated α-synuclein missense mutants.
Watt KJC; Meade RM; Williams RJ; Mason JM
J Biol Chem; 2022 Dec; 298(12):102565. PubMed ID: 36208776
[TBL] [Abstract][Full Text] [Related]
7. NMR unveils an N-terminal interaction interface on acetylated-α-synuclein monomers for recruitment to fibrils.
Yang X; Wang B; Hoop CL; Williams JK; Baum J
Proc Natl Acad Sci U S A; 2021 May; 118(18):. PubMed ID: 33903234
[TBL] [Abstract][Full Text] [Related]
8. A natural product inhibits the initiation of α-synuclein aggregation and suppresses its toxicity.
Perni M; Galvagnion C; Maltsev A; Meisl G; Müller MB; Challa PK; Kirkegaard JB; Flagmeier P; Cohen SI; Cascella R; Chen SW; Limbocker R; Sormanni P; Heller GT; Aprile FA; Cremades N; Cecchi C; Chiti F; Nollen EA; Knowles TP; Vendruscolo M; Bax A; Zasloff M; Dobson CM
Proc Natl Acad Sci U S A; 2017 Feb; 114(6):E1009-E1017. PubMed ID: 28096355
[TBL] [Abstract][Full Text] [Related]
9. Oligomers of Parkinson's Disease-Related α-Synuclein Mutants Have Similar Structures but Distinctive Membrane Permeabilization Properties.
Stefanovic AN; Lindhoud S; Semerdzhiev SA; Claessens MM; Subramaniam V
Biochemistry; 2015 May; 54(20):3142-50. PubMed ID: 25909158
[TBL] [Abstract][Full Text] [Related]
10. Prion-like C-Terminal Domain of TDP-43 and α-Synuclein Interact Synergistically to Generate Neurotoxic Hybrid Fibrils.
Dhakal S; Wyant CE; George HE; Morgan SE; Rangachari V
J Mol Biol; 2021 May; 433(10):166953. PubMed ID: 33771571
[TBL] [Abstract][Full Text] [Related]
11. Interactions between Soluble Species of β-Amyloid and α-Synuclein Promote Oligomerization while Inhibiting Fibrillization.
Candreva J; Chau E; Rice ME; Kim JR
Biochemistry; 2020 Feb; 59(4):425-435. PubMed ID: 31854188
[TBL] [Abstract][Full Text] [Related]
12. Alpha-synuclein amyloid oligomers act as multivalent nanoparticles to cause hemifusion in negatively charged vesicles.
Stefanovic AN; Claessens MM; Blum C; Subramaniam V
Small; 2015 May; 11(19):2257-62. PubMed ID: 25641873
[TBL] [Abstract][Full Text] [Related]
13. Orientation of α-Synuclein at Negatively Charged Lipid Vesicles: Linear Dichroism Reveals Time-Dependent Changes in Helix Binding Mode.
Rocha S; Kumar R; Nordén B; Wittung-Stafshede P
J Am Chem Soc; 2021 Nov; 143(45):18899-18906. PubMed ID: 34748321
[TBL] [Abstract][Full Text] [Related]
14. β-Turn exchanges in the α-synuclein segment 44-TKEG-47 reveal high sequence fidelity requirements of amyloid fibril elongation.
Agerschou ED; Schützmann MP; Reppert N; Wördehoff MM; Shaykhalishahi H; Buell AK; Hoyer W
Biophys Chem; 2021 Feb; 269():106519. PubMed ID: 33333378
[TBL] [Abstract][Full Text] [Related]
15. The role of stable α-synuclein oligomers in the molecular events underlying amyloid formation.
Lorenzen N; Nielsen SB; Buell AK; Kaspersen JD; Arosio P; Vad BS; Paslawski W; Christiansen G; Valnickova-Hansen Z; Andreasen M; Enghild JJ; Pedersen JS; Dobson CM; Knowles TP; Otzen DE
J Am Chem Soc; 2014 Mar; 136(10):3859-68. PubMed ID: 24527756
[TBL] [Abstract][Full Text] [Related]
16. Loss of native α-synuclein multimerization by strategically mutating its amphipathic helix causes abnormal vesicle interactions in neuronal cells.
Dettmer U; Ramalingam N; von Saucken VE; Kim TE; Newman AJ; Terry-Kantor E; Nuber S; Ericsson M; Fanning S; Bartels T; Lindquist S; Levy OA; Selkoe D
Hum Mol Genet; 2017 Sep; 26(18):3466-3481. PubMed ID: 28911198
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of membrane models and their composition for islet amyloid polypeptide-membrane aggregation.
Caillon L; Lequin O; Khemtémourian L
Biochim Biophys Acta; 2013 Sep; 1828(9):2091-8. PubMed ID: 23707907
[TBL] [Abstract][Full Text] [Related]
18. Potential of mean force and molecular dynamics study on the transient interactions between α and β synuclein that drive inhibition of α-synuclein aggregation.
Sanjeev A; Sahu RK; Mattaparthi VSK
J Biomol Struct Dyn; 2017 Nov; 35(15):3342-3353. PubMed ID: 27809690
[TBL] [Abstract][Full Text] [Related]
19. Direct Visualization of Model Membrane Remodeling by α-Synuclein Fibrillization.
Chaudhary H; Subramaniam V; Claessens MMAE
Chemphyschem; 2017 Jun; 18(12):1620-1626. PubMed ID: 28370874
[TBL] [Abstract][Full Text] [Related]
20. α-Synuclein Oligomers Stabilize Pre-Existing Defects in Supported Bilayers and Propagate Membrane Damage in a Fractal-Like Pattern.
Chaudhary H; Iyer A; Subramaniam V; Claessens MM
Langmuir; 2016 Nov; 32(45):11827-11836. PubMed ID: 27766878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
